---
category: news
title: "Insilico Medicine to Present at the 40th Annual J.P. Morgan Healthcare Conference"
excerpt: "Insilico Medicine (\"Insilico\"), an end-to-end artificial intelligence (AI)-driven drug discovery company, will virtually participate in the 40th Annual J.P. Morgan Healthcare Conference. Alex Zhavoronkov,"
publishedDateTime: 2022-01-07T10:55:00Z
originalUrl: "https://us.acrofan.com/detail.php?number=596729"
webUrl: "https://us.acrofan.com/detail.php?number=596729"
type: article
quality: 34
heat: 34
published: false

provider:
  name: 아크로팬
  domain: acrofan.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "http://us.acrofan.com/img/noImg.jpg"
    width: 500
    height: 324
    isCached: true

related:
  - title: "REALM IDx™ to Participate Virtually in the 40th Annual J.P. Morgan Health Care Conference"
    excerpt: "REALM IDx, Inc., a leader in integrated diagnostics, announced the company will participate in the upcoming 40th Annual J.P. Morgan Health Care Conference. This premier health care conference features global industry leaders,"
    publishedDateTime: 2022-01-06T23:57:00Z
    webUrl: "https://apnews.com/press-release/pr-newswire/technology-health-ff232c02aa05615ba640af196270be1d"
    type: article
    provider:
      name: Associated Press
      domain: apnews.com
    quality: 15
    images:
      - url: "https://apnews.com/images/PaidContent3.png"
        width: 700
        height: 450
        isCached: true
  - title: "Fosun Pharma and Insilico Medicine Announce a Strategic, AI-driven Drug Discovery and Development Collaboration to Jointly Advance Multiple Targets"
    excerpt: "This strategic collaboration includes an AI-driven drug discovery research and development (R&D) collaboration on four biological targets, as well as the co-development of Insilico's QPCTL program. Insilico will receive a total upfront payment of $13 million for the R&D collaboration projects and the co-development of the QPCTL program,"
    publishedDateTime: 2022-01-11T08:30:00Z
    webUrl: "https://www.prnewswire.com/in/news-releases/fosun-pharma-and-insilico-medicine-announce-a-strategic-ai-driven-drug-discovery-and-development-collaboration-to-jointly-advance-multiple-targets-829629042.html"
    type: article
    provider:
      name: PR Newswire
      domain: prnewswire.com
    quality: 1
    images:
      - url: "https://mma.prnewswire.com/media/1723121/Fosun.jpg?p=facebook"
        width: 1268
        height: 664
        isCached: true

secured: "xwwU7xOVs1rEAnICvIv2kQ6uX5fDFVG0r5aEZdDcwAwmMpJg2HkM1wmobWb+3TIZ8NGY9rdWAcn8ah6+tSjjQEFQq5P1eiFcKCCaQ+31kMnN3Wdtz+SW9clbkAC7tMwOuYXS8i4hr7zpOblsnDuBKmwOwviZrgrtWYxEM2w1kB/PQP6z5IqfVJBZ3Q4J7iLauYJsOSAuR9YTakC9VsLkEYGFiZhGJ6Pw/lajvbv5A7U6bAC/kEJtEEijCpXKcKhE4kGr28rrrwAyat+LaR4fHSmgova/aZf49zuLaVpDHY0NWSBuJbjRZMEzN8I+oz8F+wXSYwj4jnOmB80NgWYr9iZz0eG3wADjiugrvZtKK94=;4d51ZV0w1UI2kkqqN2xGdw=="
---

